European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab
Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1 The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2 The new liquid formulation of infliximab, available in … [Read more…]
